Q-NADMED receives CE-marking

Q-NADMED receives CE-marking

The Q-NADMED Kit for blood received CE marking at the end of May. NADMED’s kit is the only NAD measuring kit to have received marking which indicates that the kit complies with EU In Vitro Diagnostic Directive (IVDD 98/79/EC) so it can be brought to market for...
New board members

New board members

NADMED’s board is full of excellence. The new board members are Juha Tuominen, former CEO of HUS, and Ilkka Salonen, former CFO of YIT Oyj and Neste Oyj. Welcome! Prof. Anu Wartiovaara continues as the CoB and Sebastian Soidinsalo as a board...
NADMED joins HIH

NADMED joins HIH

NADMED was chosen for the Health Incubator Helsinki’s startup program among eight other life science companies with great growth potential.